• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.90% Nasdaq Up 0.71%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    7.17 Down 0.06(0.86%) 11:31AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.23
    Open:7.16
    Bid:7.18 x 400
    Ask:7.19 x 200
    1y Target Est:21.40
    Beta:3.30927
    Earnings Date:Nov 9 - Nov 13 (Est.)
    Day's Range:7.13 - 7.30
    52wk Range:6.19 - 13.04
    Volume:305,456
    Avg Vol (3m):1,489,340
    Market Cap:516.90M
    P/E (ttm):N/A
    EPS (ttm):-0.53
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INODown 0.86%516.90M
    PFEUp 0.99%199.11B
    AZNUp 2.32%81.95B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):35.35
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.57
    Quarterly EPS Est (Sep-15) :-0.04
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback